医疗鞋市场份额、规模、趋势、行业分析报告、按类型（凉鞋、鞋靴、拖鞋、鞋垫等）；按分销渠道（线上和线下）；按最终用户（男性、女性和儿童）；按地区；2020-2027年细分预测

Published Date: Dec 2020
页码：97
格式：PDF
Report ID: PM1743
基准年：2019年
历史数据：2016-2018

报告摘要

全球医疗鞋类市场价值SD 8.26 billion in 2019 and is expected to grow at a CAGR of 5.85% during the forecast period. The global market growth is attributed to rising prevalence of people suffering with diabetes mellitus leading diabetic peripheral neuropathy, innovations in foot mechanics, and awareness pertaining to feet-related ailments such as ulcers, sprain, and other foot related issues. Few notable health benefits include foot support, improved blood flow, reduction in foot pain, improved mobility, and correction with the existing foot problems.

According to the statistics published by the Children’s Hospital of Philadelphia (CHOP), the COVID-19 situation and lockdown had resulted in spike of home borne pediatric injuries coupled with strong decline of 60% in injuries with sports-related activities. The team gathered data of 1,735 patients and compared it with historic figures and found over 2.5% decline in daily road accidents leading to fractures; however, same study revealed 12% increase in home borne fractures caused due to trampoline injuries, high energy falls, and bicycle injuries. High cost of medical footwear and its availability mostly on the online platforms are acting as market restraints. Medical footwear prescribed by doctors are covered under Medicare and supplementary insurance in the U.S. and other developed economies. As a result, the demand for the products is expected to grow in North America and Europe.

了解有关此报告的更多信息:request for sample pages

Industry Dynamics

Growth Drivers
另一个推动市场增长的因素是，与脚有关的问题（如拇趾和拇趾外翻、足底筋膜炎、跟腱炎和关节炎）的发病率不断上升。根据国家生物技术信息中心（NCBI）的报告，急性跟腱腱炎的发病率在每年千分之七到四十之间，在成年人中很常见。

According to the International Diabetes Federation (IDF), about 463 million people are suffering from high blood sugar around the world in 2020. From the same source, in Southeast Asia, about 88 million people have diabetes. Out of this 88 million, 77 million people from India are diabetic. Furthermore, in January 2019, nurse practitioners as well as physicians have got permission to prescribe diabetic shoes. As a result, the demand for diabetic footwear is increasing, driving the medical footwear market growth.

医用鞋类市场报告范围

The market is primarily segmented on the basis of type, end-users, distribution channel, and geographic region.

按类型

按分销渠道

按最终用户

按地区

Sandals
Shoes & Boots
- Diabetic Shoes
- Arthritis Shoes
- 平底鞋
- Others
Insoles
Others

在线的
离线

Men
女人
Kids

北美（美国、加拿大）
欧洲（法国、德国、英国、意大利、西班牙、荷兰、奥地利）
Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
拉丁美洲（巴西、墨西哥、阿根廷）
MEA（沙特阿拉伯、阿联酋、以色列、南非）

了解有关此报告的更多信息：request for sample pages

Insight by Type

On the basis of type, the medical footwear market is bifurcated as sandals, shoes & boots, slippers, and others. Shoes segment are expected to dominate the revenue share, as shoes are preferred by both women & men as they provide maximum comfort for diabetic patients compared to sandals and slipper. The dominance is also attributed to the fact that shoes are most preferred footwear owing to their characteristics and functionality.

鞋垫市场占有第二大的收入份额，因为市场上有鞋垫，鞋垫附带有监测和帮助采取预防糖尿病措施的技术，以及医生推荐的技术。例如，在2019年12月，总部位于美国的Orpyx医疗技术公司推出了配备有远程病人监护避免糖尿病周围神经病变患者的糖尿病足溃疡复发。这些鞋垫具有视听警报功能，帮助糖尿病患者采取行动并解决可能导致组织损伤的高压区域。

分销渠道洞察

在分销渠道的基础上，将医用鞋类市场细分为线上和线下市场。2019年，在线部门的收入份额最大，因为在线平台上提供了各种各样的鞋款。此外，亚马逊（Amazon）、康福特博士（Dr Comfort）和Flipkart等电子商务网站提供多种折扣、新品发布和交易，这是推动细分市场需求的主要因素之一。

Geographic Overview

Based on region, the global medical footwear market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest revenue share in 2019 on account of increasing awareness regarding advantages of medical footwear in the U.S. and Canada. Dr Comfort is the most popular diabetic shoe brand and uses 3D printing technology for accurate fitting. Moreover, the companies in the concerned area are collaborating with technology providers to improve the performance and effectivity of the footwear.

在人群中糖尿病患病率的增加是推动北美市场的另一个因素。据美国糖尿病协会（ADA）统计，2018年约有3420万人患有糖尿病。它还测量了26.8%或1430万老年人和大约12万20岁以下的公民患有糖尿病。

Asia Pacific is projected to exhibit highest market growth due to rising cases of diabetes and large population base. India and China have huge under-served population and the rising disposable income, insurance penetration, and proper healthcare infrastructure is expected to propel the adoption of medical footwear. According to the International Diabetes Federation (IDF), India ranks second after the U.S. where the prevalence of type 1 diabetes among children is the highest. Furthermore, 2% of the total deaths in India are due to diabetes, according to the World Health Organization (WHO) report.